Document Detail


Enhanced activation of RVLM-projecting PVN neurons in rats with chronic heart failure.
MedLine Citation:
PMID:  22307669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies have indicated that there is increased activation of the paraventricular nucleus (PVN) in rats with chronic heart failure (CHF); however, it is not clear if the preautonomic neurons within the PVN are specifically overactive. Also, it is not known if these neurons have altered responses to baroreceptor or osmotic challenges. Experiments were conducted in rats with CHF (6-8 wk after coronary artery ligation). Spontaneously active neurons were recorded in the PVN, of which 36% were antidromically activated from the rostral ventrolateral medulla (RVLM). The baseline discharge rate in RVLM-projecting PVN (PVN-RVLM) neurons from CHF rats was significantly greater than in sham-operated (sham) rats (6.0 ± 0.6 vs. 2.6 ± 0.3 spikes/s, P < 0.05). Picoinjection of the N-methyl-D-aspartate (NMDA) receptor antagonist D,L-2-amino-5-phosphonovaleric acid significantly decreased the basal discharge of PVN-RVLM neurons by 80% in CHF rats compared with 37% in sham rats. Fifty-two percent of spontaneously active PVN-RVLM neurons responded to changes in the mean arterial pressure (MAP). The changes in discharge rate in PVN-RVLM neurons after a reduction in MAP (+52 ± 7% vs. +184 ± 61%) or an increase in MAP (-42 ± 8% vs. -71 ± 6%) were significantly attenuated in rats with CHF compared with sham rats. Most PVN-RVLM neurons (63%), including all barosensitive PVN-RVLM neurons, were excited by an internal carotid artery injection of hypertonic NaCl (2.1 osmol/l), whereas a smaller number (7%) were inhibited. The increase in discharge rate in PVN-RVLM neurons to hypertonic stimulation was significantly enhanced in rats with CHF compared with sham rats (134 ± 15% vs. 92 ± 13%). Taken together, these data suggest that PVN-RVLM neurons are more active under basal conditions and this overactivation is mediated by an enhanced glutamatergic tone in rats with CHF. Furthermore, this enhanced activation of PVN-RVLM neurons may contribute to the altered responses to baroreceptor and osmotic challenges observed during CHF.
Authors:
Bo Xu; Hong Zheng; Kaushik P Patel
Related Documents :
23475559 - Stp position paper: recommended practices for sampling and processing the nervous syste...
22691459 - Immunofluorescent histochemical and ultrastructural studies on the innervation of kissp...
22581849 - Opposing alterations in excitation and inhibition of layer 5 medial prefrontal cortex p...
22917619 - Treadmill training stimulates bdnf mrna expression in motor neurons of the lumbar spina...
14643079 - Using conditional mutagenesis to study the brain.
22711959 - Pancreatic insulin and exocrine secretion are under the modulatory control of distinct ...
20393059 - Multiple effects of serotonin and acetylcholine on hyperpolarization-activated inward c...
231579 - Effects of interstimulus interval on latency of the brainstem auditory evoked potential.
6683389 - Cerebral glucose utilization: local changes after microinoculation of scrapie agent in ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-02-03
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  302     ISSN:  1522-1539     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-16     Completed Date:  2012-05-30     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H1700-11     Citation Subset:  IM    
Affiliation:
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5850, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Amino-5-phosphonovalerate / pharmacology
Animals
Chronic Disease
Coronary Vessels / physiology
Electric Stimulation
Electrophysiological Phenomena
Enzyme Inhibitors / pharmacology
Excitatory Amino Acid Agonists / pharmacology
Excitatory Amino Acid Antagonists / pharmacology
Extracellular Space
Heart Failure / pathology*
Ligation
Male
Medulla Oblongata / cytology,  physiology*
Midline Thalamic Nuclei / cytology,  physiology*
N-Methylaspartate / pharmacology
Neurons / drug effects,  physiology*
Nitric Oxide Synthase Type III / antagonists & inhibitors
Osmolar Concentration
Pressoreceptors / drug effects
Rats
Rats, Sprague-Dawley
Stimulation, Chemical
omega-N-Methylarginine / pharmacology
Grant Support
ID/Acronym/Agency:
HL-62222/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Excitatory Amino Acid Agonists; 0/Excitatory Amino Acid Antagonists; 17035-90-4/omega-N-Methylarginine; 6384-92-5/N-Methylaspartate; 76726-92-6/2-Amino-5-phosphonovalerate; EC 1.14.13.39/Nitric Oxide Synthase Type III
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electromechanical and Structural Alterations in the Aging Rabbit Heart and Aorta.
Next Document:  Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca w...